Pfizer
NEWS
It was a very busy week for clinical trial news. Here’s a look.
Pfizer and BioNTech updated their development program, with plans to launch clinical trials in the U.S. and Europe across multiple sites by the end of April.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 9, 2020.
“We are pleased by the FDA’s approval of Braftovi in combination with cetuximab, as we are committed to developing targeted medicines that can help people living with certain mutation-driven cancers,” said Chris Boshoff, chief development officer, Oncology, Pfizer Global Product Development.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 8, 2020.
While the world is working to slow the COVID-19 pandemic by social isolation and quarantine, numerous companies globally are working to develop a vaccine against the virus.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 6, 2020.
Companies strengthen their leadership teams and executive boards with this week’s Movers & Shakers.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 2, 2020.
JOBS
IN THE PRESS